NVDA
NVIDIA Corporation
NVDA has the edge over SNX overall, supported by stronger valuation and stronger fundamentals.
SNX
TD SYNNEX Corporation
SNX's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
SNX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Under pressure | |
| Stable |
SNX's revenue and profitability are currently healthy, and its balance sheet is stable, but its cash flow is under pressure.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over SNX in the historical PE scenario, which offers more potential upside but is not a forecast.
SNX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 10x | $243 | — |
| Cheap | 14x | $223 | -8.2% |
| Current | 15x | $243 | — |
| Fair | 16x | $259 | +6.7% |
| Expensive | 18x | $287 | +18% |
Historical ranges are pointers, not guarantees.
SNX's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
SNX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
SNX has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over SNX on earnings, with stronger typical year-over-year growth.
SNX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $23.63 | +44% |
| Q3 2026 | $16.39 | +78% |
| Q2 2026 | $13.95 | +63% |
| Q1 2026 | $12.01 | +50% |
| Q4 2025 | $9.95 | +25% |
| Q3 2025 | $9.21 | +19% |
| Q2 2025 | $8.55 | +20% |
| Q1 2025 | $8.00 | +16% |
| Q4 2024 | $7.95 | +19% |
SNX's earnings per share have climbed steadily: $16.39 over the past year, up 78% from the year before, and higher year over year for 10 quarters in a row.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over SNX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over SNX on profitability, with a higher operating margin.
SNX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21.6B | +38% |
| Q2 2026 | $19.6B | +31% |
| Q1 2026 | $17.2B | +18% |
| Q4 2025 | $17.4B | +9.7% |
| Q3 2025 | $15.7B | +6.6% |
| Q2 2025 | $14.9B | +7.2% |
| Q1 2025 | $14.5B | +4% |
| Q4 2024 | $15.8B | +10% |
SNX's revenue has grown year over year for nine quarters in a row: $21.6B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3% | +0.5 points |
| Q2 2026 | 2.6% | +0.4 points |
| Q1 2026 | 2.9% | +0.8 points |
| Q4 2025 | 2.3% | +0.2 points |
| Q3 2025 | 2.5% | +0.4 points |
| Q2 2025 | 2.2% | +0.3 points |
| Q1 2025 | 2.1% | -0.1 points |
| Q4 2024 | 2% | +0.1 points |
SNX's operating margin was 3% last quarter, up 0.5 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over SNX on cash generation, producing positive trailing cash flow while its opponent burns cash.
SNX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$975.6M | -556% |
| Q2 2026 | -$332.4M | -161% |
| Q1 2026 | -$929M | -$139.5M |
| Q4 2025 | $1.4B | +177% |
| Q3 2025 | $213.9M | -37% |
| Q2 2025 | $542.9M | +$695.5M |
| Q1 2025 | -$789.5M | -330% |
| Q4 2024 | $512.9M | +205% |
SNX's free cash flow has turned negative after years in the green: −$815M over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
SNX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -342K shares |
| 1 year | -3% | -2.5M shares |
| 3 years | -15% | -13.5M shares |
| 5 years | +54% | +27.7M shares |
| Available history | -22% | -22.5M shares |
SNX has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100.3M |
| Q2 2026 | $112.4M |
| Q1 2026 | $79.7M |
| Q4 2025 | $173M |
| Q3 2025 | $173.8M |
| Q2 2025 | $148.8M |
| Q1 2025 | $100.5M |
| Q4 2024 | $102M |
SNX spent $465M buying back its own shares over the past year, down 11% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over SNX on leverage, with a lower net debt burden relative to earnings.
SNX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.4x | Moderate |
| Q4 2024 | 1.8x | Healthy |
SNX's net debt is about 1.9 years of its operating earnings (EBITDA), about the same as a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
SNX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.0 | Neutral |
| Stochastic | 17.1 | Oversold |
SNX's weekly RSI is 50 (neutral) and its Stochastic is 17 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
SNX PE vs Technology Sector
| Metric | SNX | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 28x | 47% below |
| PE % | 30 | 35 | 5 pts below |
SNX has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
SNX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $250.8 | 3.3% below |
| 20 week MA | $252.9 | 4.1% below |
| 50 week MA | $216.8 | 12% above |
| 100 week MA | $176.2 | 38% above |
| 200 week MA | $141.2 | 72% above |
SNX has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
SNX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $64.6 | $82.7 | +28% |
| 2021 | $82.7 | $113.2 | +37% |
| 2022 | $113.2 | $95.2 | -16% |
| 2023 | $95.2 | $107.6 | +13% |
| 2024 | $107.6 | $118.3 | +10% |
| 2025 | $118.3 | $154.9 | +31% |
| 2026 YTD | $154.9 | $242.5 | +57% |
SNX has the edge over NVDA on returns for 2026, with the stronger performance.